28.11.2014 Views

Гласник интелектуалне својине 2012/04 - Завод за ...

Гласник интелектуалне својине 2012/04 - Завод за ...

Гласник интелектуалне својине 2012/04 - Завод за ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Гласник интелектуалне својине <strong>2012</strong>/4<br />

Intellectual Property Gazette <strong>2012</strong>/4<br />

(54) COMBINED TABLET FORM AND<br />

PROCEDURES FOR PRODUCTION THEREOF<br />

(57) Invention herewith described refers to the new form<br />

of combined tablets, containing four active components<br />

such as paracetamol from 35 to 45% w/w of the total<br />

tablet mass, propyphenazone from 25 to 37% w/w of the<br />

total tablet mass, codeine phosphate from 1.1 to 1.9%<br />

w/w of the total tablet mass and caffeine from 5 to 9%<br />

w/w of the total tablet mass as well as to the processes<br />

for the production thereof.<br />

(51) A 61 K 9/20 (2006.01)<br />

A 61 K 31/138 (2006.01)<br />

A 61 K 31/4422 (2006.01)<br />

(11) 2011/0136<br />

(13) A1<br />

(21) P-2011/0136 (22) 30.09.2009.<br />

(30) HU 30.09.2008. P0800591<br />

(86) WO 30.09.2009. PCT/HU2009/000085<br />

(87) WO 08.<strong>04</strong>.2010. WO 2010/038091<br />

(54) PREPARATI KOJI SADRŽE AMLODIPIN I<br />

BIZOPROLOL<br />

(71) EGIS GYÓGYSZERGYÁR NYILVÁNOSAN<br />

MŰKÖDŐ RÉSZVÉNYTÁRSASÁG, Keresztúri út. 30-<br />

38, H-1106 Budapest, HU<br />

(72) WAGNER, László, XI. utca 36, H-1172 Budapest,<br />

HU; ZSIG-MOND, Zsolt, Mátyás király u. 67, H-2234<br />

Maglód, HU; UJFALUSSY, György, Dózsa György u.<br />

13, H-1028 Budapest, HU; LEVENTISZNÉ, HUSZÁR,<br />

Magdolna, Virányos út 24/a, H-1125 Budapest, HU;<br />

TONKA-NAGY, Péter, Ököl u. 4/b 9, H-117l Budapest,<br />

HU; BÁR-CZAY, Erzsébet, Bökényföldi u. 23, H-1165<br />

Budapest, HU; GÓRA, Lászlóné, Gyöngyvirág u. 3, H-<br />

2117 Isaszeg, HU; SZELECZKI, Edit, Osztály u. 6-10/D<br />

1.2, H-1165 Budapest, HU; FÜLÖP, Ágnes, Szilágyi<br />

Dezső u. 87, H-1174 Budapest, HU<br />

(74) RISTIĆ, Dragoslav i MALEŠEVIĆ, Vladan,<br />

Cara Lazara 7, 11000 Beograd, RS<br />

(57) Predmetni pronalazak se odnosi na stabilni čvrsti<br />

farmaceutski preparat koji sadrži amlodipin ili njegove<br />

farmaceutski prihvatljive soli i bizoprolol ili njegove<br />

farmaceutski prihvatljive soli, kao i farmaceutski<br />

prihvatljive ekscipijense, upakovane u pakovanje<br />

nepropusno za vlagu, te koji dalje sadrži manje od 0, 5%<br />

jedinjenja sa formulom (3), u odnosu na masu aktivnih<br />

sastojaka.<br />

(54) COMPOSITIONS COMRRISING AMLODIPINE<br />

AND BISOPROLOL<br />

(57) Stable solid pharmaceutical composition containing<br />

amlodipine or pharmaceutical acceptable salts thereof<br />

and bisoprolol or pharmaceutical acceptable salts thereof<br />

as well as pharmaceutically accepted excipients,<br />

packaged in a damp- proof package and further<br />

comprising less than 0.5 % of the compound of the<br />

formula (3) based on the weight of the active ingredients.<br />

(51) A 61 K 9/20 (2006.01)<br />

A 61 K 31/485 (2006.01)<br />

A 61 K 9/00 (2006.01)<br />

(11) 2011/0564<br />

(13) A2<br />

(21) P-2011/0564 (22) 02.05.2002.<br />

(62) P-860/03<br />

(30) US 02.05.2001. 60/288,211<br />

(54) JEDNODNEVNE FORMULACIJE OKSIKODONA<br />

(71) EURO-CELTIQUE S.A., 2, Avenue Charles de Gaulle,<br />

1653 Luxembourg, LU<br />

(72) OSHLACK, Benjamin, 351 East 84th Street, New<br />

York, NY 10028, US; WRIGHT, Curtis, 1 Jarvis Street,<br />

Norwalk, CT 06851, US; PRATER, Derek, 28 Pearson<br />

Close, Milton, Cambridge, GB<br />

(74) JANKOVIĆ D.Ivan i ost., 11000 Beograd,<br />

Vlajkovićeva 28, RS<br />

(57) Pronalazak se odnosi na formulacije sa odloženim<br />

oslobađanjem koje sadrže oksikodon ili njegovu<br />

farmaceutski prihvatljivu so, koje obezbeđuje srednji<br />

C 24 /C max oksikodona od 0, 6 do 1, 0 ili 0, 7 do 1 posle<br />

davanja oralnim putem pri stabilnom stanju pacijentima i<br />

na postupke u vezi sa njima.<br />

(54) DIURNAL FORMULATION OF OXYCODONE<br />

(57) Invention herewith described refers to the delayed<br />

release formulations containing oxycodone or its<br />

pharmaceutically acceptable salt, which provides<br />

medium C 24 /C max of oxycodone from 0.6 to 1.0 or 0.7 to<br />

1 after administering orally in stable condition to patients<br />

and the procedures related thereto.<br />

(51) A 61 K 31/505 (2006.01)<br />

C 07 D 239/28 (2006.01)<br />

A 61 P 37/08 (2006.01)<br />

(11) <strong>2012</strong>/0098<br />

(13) A1<br />

(21) P-<strong>2012</strong>/0098 (22) 31.01.2003.<br />

(30) US 01.02.2002. 60/353333<br />

US 01.02.2002. 60/353267<br />

US 29.07.2002. 60/399673<br />

US 17.12.2002. 60/434277<br />

(86) 31.03.2003. PCT/US/2003/03022<br />

(87) 07.08.2003. WO 2003/063794<br />

(54) JEDINJENJA 2,4-PIRIMIDINDIAMINA I NJIHOVA<br />

UPOTREBA<br />

(71) RIGEL PHARMACEUTICALS INC, 1180 Veterans<br />

Boulevard, 94080 South San Francisco, CA, US<br />

A<br />

ЗИС / RS / IPO 1903

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!